Lung Yeh Cho
Directeur/Membre du Conseil chez OBI PHARMA, INC.
Profil
Lung Yeh Cho is currently a Director at OBI Pharma, Inc. and Renbio Holdings Ltd.
He previously held Director positions at TaiMed Biologics, Inc., Diamond BioFund Inc, Tanvex BioPharma, Inc., RenBio, Inc., and was a Partner at KPMG Taiwan Inc. He obtained an undergraduate degree from National Taipei University.
Postes actifs de Lung Yeh Cho
| Sociétés | Poste | Début |
|---|---|---|
| OBI PHARMA, INC. | Directeur/Membre du Conseil | 07/02/2013 |
| Renbio Holdings Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lung Yeh Cho
| Sociétés | Poste | Fin |
|---|---|---|
KPMG Taiwan Inc.
 KPMG Taiwan Inc. Investment ManagersFinance KPMG Taiwan Inc. provides financial advisory services. The private company is based in Taipei, Taiwan. The Taiwanese company was founded by Kuo Feng Wu, Pao Kuei Chu. The CEO is Kwo-Juh Maa. | Corporate Officer/Principal | - |
Diamond BioFund Inc /Investment/
 Diamond BioFund Inc /Investment/ Investment ManagersFinance Diamond BioFund Inc (Diamond BioFund) is an independent venture capital firm founded in 2013 by Microbio Group, Fubon Financial, Taishin Holdings and Ruentex Group. The firm is headquartered in Taipei, Taiwan. | Directeur/Membre du Conseil | - |
RenBio, Inc.
 RenBio, Inc. BiotechnologyHealth Technology RenBio, Inc. is a preclinical biotechnology company based in New York, NY. The company is focused on developing novel antiviral antibody therapeutics and a next-generation antibody delivery platform. RenBio's lead compound, rb-100, is a SARS-CoV-2 bispecific antibody that has demonstrated robust antiviral activity against emerging and evolving SARS-CoV-2 variants. The company is also developing a revolutionary, next-generation nucleic acid-based antibody delivery platform called Myo (Make Your Own) Technology™. RenBio was co-founded by David D. Ho, a world-renowned HIV expert and founding scientific director of the Aaron Diamond AIDS Research Center, and Yaoxing Huang, an associate professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons. The company has received non-dilutive financing from the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and MedImmune (now AstraZeneca). | Directeur/Membre du Conseil | - |
| TAIMED BIOLOGICS INC. | Directeur/Membre du Conseil | - |
| TANVEX BIOPHARMA, INC. | Directeur/Membre du Conseil | - |
Formation de Lung Yeh Cho
| National Taipei University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| TANVEX BIOPHARMA, INC. | Health Technology |
| TAIMED BIOLOGICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
RenBio, Inc.
RenBio, Inc. BiotechnologyHealth Technology RenBio, Inc. is a preclinical biotechnology company based in New York, NY. The company is focused on developing novel antiviral antibody therapeutics and a next-generation antibody delivery platform. RenBio's lead compound, rb-100, is a SARS-CoV-2 bispecific antibody that has demonstrated robust antiviral activity against emerging and evolving SARS-CoV-2 variants. The company is also developing a revolutionary, next-generation nucleic acid-based antibody delivery platform called Myo (Make Your Own) Technology™. RenBio was co-founded by David D. Ho, a world-renowned HIV expert and founding scientific director of the Aaron Diamond AIDS Research Center, and Yaoxing Huang, an associate professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons. The company has received non-dilutive financing from the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and MedImmune (now AstraZeneca). | Health Technology |
| Renbio Holdings Ltd. | |
Diamond BioFund Inc /Investment/
Diamond BioFund Inc /Investment/ Investment ManagersFinance Diamond BioFund Inc (Diamond BioFund) is an independent venture capital firm founded in 2013 by Microbio Group, Fubon Financial, Taishin Holdings and Ruentex Group. The firm is headquartered in Taipei, Taiwan. | Finance |
KPMG Taiwan Inc.
KPMG Taiwan Inc. Investment ManagersFinance KPMG Taiwan Inc. provides financial advisory services. The private company is based in Taipei, Taiwan. The Taiwanese company was founded by Kuo Feng Wu, Pao Kuei Chu. The CEO is Kwo-Juh Maa. | Finance |